• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[结直肠癌中CD8+T细胞浸润特征及其与预后的相关性]

[Characteristics of CD8+ T cell infiltration in colorectal cancer and their correlation with prognosis].

作者信息

Zou Q, Hu B, Yu H C, Ren D L

机构信息

Department of Colorectal and Anal Surgery, The Sixth Affiliated Hospital, Sun Yet-sen University, Guangzhou 510655, China Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China.

Department of Colorectal and Anal Surgery, The Sixth Affiliated Hospital, Sun Yet-sen University, Guangzhou 510655, China.

出版信息

Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Dec 25;24(12):1086-1092. doi: 10.3760/cma.j.cn441530-20210402-00144.

DOI:10.3760/cma.j.cn441530-20210402-00144
PMID:34923792
Abstract

As cytotoxic T cells, CD8+ T lymphocytes can kill tumor cells by releasing perforin and other effector molecules, but the correlation between their infiltration level and the prognosis of colorectal cancer varies in previous studies. This study aims to explore the distribution of CD8+T cells in tumor center and invasive margin of colorectal cancer, and to analyze their correlation with the prognosis of patients. A retrospective cohort study was used to analyze the clinicopathological features of 221 patients with colorectal cancer from the colorectal cancer pathological database of the Sixth Affiliated Hospital of Sun Yat-sen University between 2009 and 2012. Case inclusion criteria: (1) colorectal cancers confirmed by postoperative pathology; (2) patients with follow-up data. Exclusion criteria: (1) multiple primary cancers; (2) inflammatory bowel disease, Lynch syndrome or familial adenomatous polyposis; (3) no available paraffin slides; (4) patients receiving preoperative radiotherapy or chemotherapy. A total of 221 patients met the criteria. Immunohistochemical staining was used to count the CD8+ T cells in tumor center and invasive margin in the paraffin slides. Meanwhile the relative expression of CD8B gene in 22 fresh freeze samples of colorectal cancer was detected. Then the correlation of the expression with CD8+T cell density was examined. The patients were divided into high and low infiltration groups according to the level of CD8+T cells. Log-rank test was applied to compare the overall survival of the two groups of patients, and Cox regression analysis was used to adjust the prognostic significance of CD8+T cell infiltration. There were 118 males and 103 females. In 221 slides, CD8+T cells infiltrating in invasive margin were more than those in tumor center [median (range): 37(0-141) / field vs. 14(0-106) / field, =-11.985, <0.001], and the number of CD8+T cell in the tumor center was positively correlated with those in invasive margin (=0.610, <0.001). The number of CD8+ T cell in tumor center was positively correlated with the relative expression of CD8B gene (=0.524, =0.012). Survival analysis showed that the overall survival of the high infiltration group was better than that of the low infiltration group both in tumor center and invasive margin (median survival: 84.1 months vs. 73.5 months, <0.001; 84.2 months vs. 75.9 months, =0.002). Cox regression analysis revealed that high CD8+T cell infiltration in tumor center was an independent protective factor of overall survival (HR=0.369, 95% CI: 0.168-0.812, =0.013). The infiltration level of CD8+T cells in tumor center is lower than that in invasive margin, and they are positively correlated. The level of CD8+ T cell infiltration in tumor center is related to overall survival and can be used as a potential pronostic marker.

摘要

作为细胞毒性T细胞,CD8 + T淋巴细胞可通过释放穿孔素和其他效应分子来杀伤肿瘤细胞,但在以往研究中,其浸润水平与结直肠癌预后的相关性存在差异。本研究旨在探讨CD8 + T细胞在结直肠癌肿瘤中心和浸润边缘的分布情况,并分析其与患者预后的相关性。采用回顾性队列研究,分析2009年至2012年中山大学附属第六医院结直肠癌病理数据库中221例结直肠癌患者的临床病理特征。病例纳入标准:(1)术后病理确诊为结直肠癌;(2)有随访数据的患者。排除标准:(1)多原发性癌;(2)炎症性肠病、林奇综合征或家族性腺瘤性息肉病;(3)无可用石蜡切片;(4)接受术前放疗或化疗的患者。共有221例患者符合标准。采用免疫组织化学染色法对石蜡切片中肿瘤中心和浸润边缘的CD8 + T细胞进行计数。同时检测22例新鲜冷冻的结直肠癌样本中CD8B基因的相对表达。然后检测该表达与CD8 + T细胞密度的相关性。根据CD8 + T细胞水平将患者分为高浸润组和低浸润组。采用对数秩检验比较两组患者的总生存期,并采用Cox回归分析调整CD8 + T细胞浸润的预后意义。男性118例,女性103例。在221张切片中,浸润边缘的CD8 + T细胞多于肿瘤中心[中位数(范围):37(0 - 141)/视野 vs. 14(0 - 106)/视野,=-11.985,<0.001],肿瘤中心的CD8 + T细胞数量与浸润边缘的呈正相关(=0.610,<0.001)。肿瘤中心CD8 + T细胞数量与CD8B基因的相对表达呈正相关(=0.524,=0.012)。生存分析显示,高浸润组在肿瘤中心和浸润边缘的总生存期均优于低浸润组(中位生存期:84.1个月 vs. 73.5个月,<0.001;84.2个月 vs. 75.9个月,=0.002)。Cox回归分析显示,肿瘤中心高CD8 + T细胞浸润是总生存期的独立保护因素(HR = 0.369,95%CI:0.168 - 0.812,=0.013)。肿瘤中心CD8 + T细胞的浸润水平低于浸润边缘,且二者呈正相关。肿瘤中心CD8 + T细胞浸润水平与总生存期相关,可作为潜在的预后标志物。

相似文献

1
[Characteristics of CD8+ T cell infiltration in colorectal cancer and their correlation with prognosis].[结直肠癌中CD8+T细胞浸润特征及其与预后的相关性]
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Dec 25;24(12):1086-1092. doi: 10.3760/cma.j.cn441530-20210402-00144.
2
[Prognostic value of tumor infiltration immune cells in pancreatic cancer].[肿瘤浸润免疫细胞在胰腺癌中的预后价值]
Zhonghua Wai Ke Za Zhi. 2018 Jun 1;56(6):464-470. doi: 10.3760/cma.j.issn.0529-5815.2018.06.015.
3
[Clinicopathological characteristics of type 2 diabetes mellitus complicated with colorectal cancer].2型糖尿病合并结直肠癌的临床病理特征
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Oct 25;22(10):966-971. doi: 10.3760/cma.j.issn.1671-0274.2019.10.012.
4
CD8-positive T Cell Infiltration With Human Leukocyte Antigen Class 1 Expression Predicts Patients With Stage IV Colorectal Cancer Survival.CD8 阳性 T 细胞浸润伴人类白细胞抗原 I 类表达预测 IV 期结直肠癌患者的生存。
Anticancer Res. 2024 Apr;44(4):1603-1610. doi: 10.21873/anticanres.16958.
5
Prognostic value of the density of tumor-infiltrating lymphocytes in colorectal cancer liver metastases.肿瘤浸润淋巴细胞密度在结直肠癌肝转移中的预后价值
Oncol Lett. 2021 Dec;22(6):837. doi: 10.3892/ol.2021.13098. Epub 2021 Oct 18.
6
Prognostic significance of CD8+ T-cells density in stage III colorectal cancer depends on SDF-1 expression.CD8+T 细胞密度在 III 期结直肠癌中的预后意义取决于 SDF-1 的表达。
Sci Rep. 2021 Jan 12;11(1):775. doi: 10.1038/s41598-020-80382-2.
7
[Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].[术前外周血淋巴细胞与单核细胞比值对Ⅲ期结肠癌患者预后的评估价值]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Jan 25;22(1):73-78.
8
Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer.CD8 + T细胞和巨噬细胞在结直肠癌肿瘤周围浸润的预后意义
Oncol Rep. 2003 Mar-Apr;10(2):309-13.
9
Validation of the prognostic value of CD3 and CD8 cell densities analogous to the Immunoscore® by stage and location of colorectal cancer: an independent patient cohort study.验证 CD3 和 CD8 细胞密度对结直肠癌分期和部位的预后价值类似于免疫评分®:一项独立的患者队列研究。
J Pathol Clin Res. 2023 Mar;9(2):129-136. doi: 10.1002/cjp2.304. Epub 2022 Nov 24.
10
[Prognostic value of combining preoperative serum tumor markers and peripheral blood routine indexes in patients with colorectal cancer].[术前血清肿瘤标志物与外周血血常规指标联合检测对结直肠癌患者的预后价值]
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Dec 25;21(12):1421-1426.

引用本文的文献

1
Application of single-cell sequencing in the study of immune cell infiltration in inflammatory bowel disease and colorectal cancer.单细胞测序在炎症性肠病和结直肠癌免疫细胞浸润研究中的应用。
World J Gastrointest Oncol. 2025 Jun 15;17(6):107382. doi: 10.4251/wjgo.v17.i6.107382.
2
The characteristics of the tumor immune microenvironment in colorectal cancer with different MSI status and current therapeutic strategies.不同微卫星不稳定性(MSI)状态的结直肠癌肿瘤免疫微环境特征及当前治疗策略
Front Immunol. 2025 Jan 14;15:1440830. doi: 10.3389/fimmu.2024.1440830. eCollection 2024.
3
Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?
浸润肿瘤的淋巴细胞治疗实体瘤:需要双人探戈?
Front Immunol. 2022 Oct 28;13:1018962. doi: 10.3389/fimmu.2022.1018962. eCollection 2022.
4
Synergistic Effect of Huangqin Decoction Combined Treatment With Radix on DSS and AOM-Induced Colorectal Cancer.黄芩汤联合茜草治疗对葡聚糖硫酸钠(DSS)和氧化偶氮甲烷(AOM)诱导的结直肠癌的协同作用。
Front Pharmacol. 2022 Jul 6;13:933070. doi: 10.3389/fphar.2022.933070. eCollection 2022.